ERYTECH completes enrollment in its Phase III study in Acute Lymphoblastic Leukemia

  • Post author:
  • Post category:Newsroom

ERYTECH announces the completion of the enrollment of patients in its pivotal Phase III study in Acute Lymphoblastic Leukemia (ALL).

Menu